Ntuziaka maka ịgbanye insulin na-enweghị agịga maka ndị ọrịa shuga

E weputara "Ntuziaka maka ịgbanye insulin na-enweghị agịga maka ndị na-arịa ọrịa shuga" na China, bụ nke gosipụtara ntinye ntinye insulin na-enweghị agịga n'usoro ọgwụgwọ ọrịa shuga nke China, ma meekwa ka China bụrụ obodo gọọmentị maka nkwalite nke enweghị agịga. teknụzụ ogwu ogwu.
N'otu oge ahụ, a malitere ịkwalite ịgba ọgwụ insulin na-enweghị agịga na mba niile, ma jiri sirinji na-enweghị agịga mee ihe n'ime ngalaba narị ụlọ ọgwụ dị na China, na-aghọ ngwaọrụ mbụ na-enweghị agịga na-anabata dị ka ngwá ọrụ ọgwụgwọ.
Dị ka ụlọ ọrụ na-eduga n'ọhịa nke ịgba ogwu na-enweghị agịga na China, ihe ọhụrụ na-aga n'ihu nke teknụzụ jet "TECHiJET" achọpụtala n'ụdị dabara adaba nke ụdị "TECHIJET" na-enweghị agịga na-enweghị ọgwụ na ọgwụ dị iche iche, yana njikwa ziri ezi. nke omimi injection na ebe mgbasa., iji kwado ọgwụ ahụ iji nweta mmalite kachasị mma.Ya mere, sirinji na-enweghị TECHiJETneedle abụghị naanị ngwa mmeghe dị mfe, kamakwa usoro ọgwụgwọ nnyefe ọgwụ.

Tupu etinye ya n'ụlọọgwụ ahụ, "TECHIJET" emeela ọnụ ọgụgụ dị ukwuu nke ụlọ ọgwụ res earch experiments.
The "Pharmacokine ics na Pharmacodyna mics Study of Humalog enweghị agịga injection" rụrụ site Profess ma ọ bụ Li Qifu nke First Mgbakwunye H ospital nke Chongqing Medical University na 2015 confir med na tụnyere na agịga-frees yringe nke "TECHiJET" agịga-free sirinji, nnabata nke insulin ngwa ngwa na nso usoro nzuzo nke insulin physiological;

atụmatụ

Na 2016, ọmụmụ "Tụnyere mmetụta s nke agịga -fr ee inject ion na omenala insu lin pen on bloo d sugar control na insulin etoju na ndị ọrịa na T 2DM" nkwonkwo rụrụ site Prọfesọ Xiao Xinhua nke Peking Union Medical College H. osp ital na Prọfesọ Guo Lix na ụlọ ọgwụ Beijing kwuputara med: "Qu ick Shure" agịga na-enweghị atụ atụnyere ya na agịga h,
postprandia l njikwa shuga dị n'ọbara ka mma, na mgbanwe shuga ọbara postprandial dị obere;
Malite na 2018, ọ dịruo afọ 2 wee bụrụ onye Profess ma ọ bụ Ji Linong sitere na ụlọ ọgwụ Peop le's na Beijing wee jiri nkwonkwo malite ọmụmụ P Hase III na ụlọ ọgwụ iri kacha elu.Ọmụmụ ihe "FREE" na-eji "T ECHIJET" agịga-fr ee yringe bụ ugbu a t ọ kachasị n'ụwa.Ndị na-ahụ maka ihe ngosi ọla edo nke ọbara su gar control "glycat ed hemoglobin" dị ka isi nrụpụta ọrụ obs er vation index, n'okpuru es erch nke ndị ọkachamara endocrinology nke C Hina, kwadoro uru nke "TECHiJET" na-enweghị agịga. technology res earch na ịzụlite ment innovation ikike, ma na-egosipụta ed China's no Innovation and clinical ngwa valu e of clinica l res erch on agịga igba ion t echnology.Ọmụmụ ihe "FREE" gosipụtara nkwubi okwu ndị a:
E jiri ya tụnyere insulin h na agịga h, mgbanwe site na isi mmalite na HbA1c na-enweghị agịga abụghị ihe dị n'ụdị insulin p en otu, ma nwee ọnụ ọgụgụ dị elu karịa na ụlọ ọgwụ; Insulin nke insulin karịa injection pen insulin; Ọ dịghị agịga ịgbanye ion nke insu lin, mmeghachi omume mmeghachi omume ọjọọ na ebe a na-agba ọgwụ adịghị obere, ọ dịghịkwa induration adịghị eme; ndidi afọ ojuju, nke nwere ike ime ka ove ndidi nnabata." TECHiJET" ga-anọgide na-e na-edu ụwa agịga -fr nke injection technology dị ka isi na-erite uru ndị ọrịa na-eme ka nlekọta ahụike dị mma.Ọ bụ r espons ibility a na ezigbo "T ECHIJET" iji kwalite e na nkà mmụta sayensị na nkà na ụzụ ọganihu nke mba ọgwụ aku na uba, na ọhụụ nke "ndụ-free diagnos bụ na-emeso ment, na-eme ka ụwa a mma ebe" ga n'ezie a ga-enweta ozugbo enwere ike.


Oge nzipu: Ọktoba 13-2022